How to get Wegovy for weight loss in the UK

Wegovy (semaglutide) is a prescription-only medicine — a prescriber must assess your suitability before any pharmacy can dispense it
The licensed eligibility starting point is a BMI of 30 or above, or 27 or above if you have at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes
Treatment begins at a low dose (0.25 mg) and is increased gradually over several weeks by your prescriber — self-adjusting the schedule is not advised
NHS access to Wegovy exists but is limited to specialist weight management services; private prescription through a GPhC-registered online pharmacy is the alternative for people who cannot wait

Getting Wegovy for weight loss in the UK starts with a single step: a clinical assessment with a prescriber. Wegovy (semaglutide) is a prescription-only medicine, meaning no pharmacy can dispense it without one. The good news is that a regulated online pharmacy can carry out that assessment quickly, without a GP referral or a waiting list. Here is what the process actually involves, and what to think through before you begin.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What to weigh up before you try to get Wegovy for weight loss

The decision you're actually making

If you've searched for how to get Wegovy for weight loss, you're probably past the curiosity stage. You've likely read enough to know this is a GLP-1 receptor agonist that reduces appetite by mimicking a gut hormone your body already produces. What you're deciding now is whether to pursue it, and through which route.

That's a reasonable place to feel a little uncertain. There's a lot of noise online, prices that seem too good to be true, sellers with no obvious medical oversight, and a gap between what the NHS offers and what's actually available to most people today.

The honest frame is this: Wegovy is a licensed medicine with a real evidence base. The STEP 1 trial, published in the New England Journal of Medicine, found an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. But it is a prescription medicine, clinical assessment comes first, and suitability varies from person to person. If you want to understand how it actually works in the body before going further, our explanation of how Wegovy works for weight loss covers the mechanism clearly.

The decision tree has two main branches: NHS access or private prescription. Both are legal and both require clinical oversight. What differs is speed, criteria, and cost.

NHS access: what the criteria actually say right now

Wegovy is available on the NHS, but access is narrow. NICE's appraisal of semaglutide (TA875) recommends it only when prescribed within a specialist weight management service offering multidisciplinary support, for a maximum of two years, and for adults with a BMI of 35 or above plus at least one weight-related comorbidity. Ethnic-background thresholds are typically 2.5 kg/m² lower under UK guidance.

Waiting lists for specialist weight management services are commonly long, and not every GP practice is actively referring into them. If your BMI sits between 27 and 34.9, the NHS route for Wegovy specifically may not be open to you at all, regardless of other health factors.

For a broader look at what's available and how the two routes compare, our Wegovy and weight loss overview sets it out plainly. The NHS is the right route if you meet the criteria and can wait; private prescription exists for everyone else who qualifies clinically.

Private prescription: who can get it and what the process involves

Through a GPhC-registered online pharmacy, the eligibility is set by the medicine's UK licence. Adults with a BMI of 30 or above, or 27 or above with a qualifying weight-related condition, may be considered. A prescriber looks at the full picture (your medical history, current medicines, any contraindications) before making a decision. BMI alone does not guarantee a prescription; the clinical assessment is what matters.

At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, the same day it is submitted. There is no algorithm making the call. Photo ID and live weight verification happen as part of the process, and your GP is notified in line with GPhC guidance. You can verify our pharmacy on the official GPhC register at GPhC registration 9012878.

If you want to understand what the first few weeks look like practically, our guide to how you take Wegovy for weight loss walks through the dose schedule and what to expect. And if cost is part of your thinking, our Wegovy cost context page explains honestly what drives private pricing and what a legitimate service includes.

Red flags to watch for when looking to get Wegovy online

The demand for GLP-1 medicines has created a market for fake and illegally sold products. The MHRA has seized around 20 million doses of illegally traded weight-loss medicines, worth approximately £45 million, and raided the UK's first illicit site producing counterfeit tirzepatide pens. Fake pens have contained insulin rather than the labelled medicine, with serious consequences for people who received them.

Sellers offering Wegovy without requiring a prescription, social-media accounts advertising it at steeply discounted prices, and sites with no verifiable pharmacy registration are all warning signs. A legitimate regulated pharmacy will always require a clinical assessment, will appear on the GPhC pharmacy register, and will not offer a medicine at a price so far below the market rate that it raises obvious questions.

If you want to understand the semaglutide medicine itself in more depth before going further, our semaglutide information page covers the active ingredient clearly. And when you're ready to take the first step, you can speak to our prescribers through a free consultation with no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions